|
|
|
| home > white papers > Contemporary Issues in Comparator Trial Supply - Clinigen CTS |
|
|
 WHITE PAPERS |
|
Clinigen CTS
|
|
Contemporary Issues in Comparator Trial Supply
|
|
The past five years has seen a great deal of change in clinical trial management. As the bio-pharma industry looks to speed development times and consolidate new product pipelines, in a quest for improved R&D efficiency, it is no surprise that phase III trial design, planning and execution in particular has been under great scrutiny. Cost of comparator agents alone has escalated to up to $100m per year for top companies (and is predicted to grow further). Consequently innovative approaches, novel project planning and increasingly close partnerships with specialist outsourcing service providers have come to the fore.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Cognizant Shared Investigator Platform for Life Sciences Reaches Major Milestone in Accelerating Drug Discovery
Cognizant (Nasdaq: CTSH) announced that its Shared Investigator Platform
(SIP), a life sciences Software as a Service (SaaS) solution, has
reached a new milestone of over 100,000 users in 84 countries. The
platform has become increasingly critical to progressing clinical trials
as prevailing social distancing norms have significantly curtailed
in-person collaboration.
More info >> |
|
 |
White Papers |
 |
|
Antibody Internalization: Advanced Flow Cytometry and Live-Cell Analysis Give Rich Insights During Antibody Profiling
Sartorius Group
The natural characteristics of antibodies, such as high binding affinity, specificity to a wide variety of targets, and good stability, make them ideal therapeutic candidates for many diseases. Monoclonal antibodies (mAbs), in particular, deliver promising therapeutic results in several different disease areas, such as autoimmunity, oncology, and chronic inflammation. Researchers’ abilities to improve the breadth of antibodies have been aided by innovative technologies for antibody discovery, for instance, through humanization of mouse antibodies and phage display. However, advanced antibody design techniques create the need for new screening methods so that lead candidates can be quickly and effectively identified as early in the development process as possible.
More info >> |
|
 |
Industry Events |
 |
Outsourcing in Clinical Trials Europe
26-27 October 2020, Paris, France
Arena International are delighted to announce the return of Outsourcing
in Clinical Trials Europe. Part of our global series of events, this
flagship show will attract the leading clinical professionals from
across Europe. The 10th Annual event will be hosted in Paris.
More info >> |
|
|
|
.jpg)
